World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
118
Citations
53644
World Ranking
4046
National Ranking
2216

Norbert F. Voelkel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Norbert F. Voelkel sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 563 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Norbert F. Voelkel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Norbert F. Voelkel sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 118 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Norbert F. Voelkel is affiliated with Virginia Commonwealth University in the United States. Their research primarily focuses on medicine, with a significant emphasis on pulmonary and respiratory medicine.

Their work spans several subfields including pulmonary and respiratory medicine, cardiology and cardiovascular medicine, physiology, critical care and intensive care medicine, and surgery.

Key topics in Norbert F. Voelkel's research include:

  • Pulmonary Hypertension Research and Treatments
  • Respiratory Support and Mechanisms
  • Asthma and respiratory diseases
  • Renin-Angiotensin System Studies
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Neonatal Respiratory Health Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Notable recent papers authored or co-authored by Norbert F. Voelkel cover various aspects of lung diseases and pulmonary hypertension, including:

  • "The vascular perspective on acute and chronic lung disease" (2023) published in Journal of Clinical Investigation
  • "The hallmarks of severe pulmonary arterial hypertension: the cancer hypothesis-ten years later" (2020) published in American Journal of Physiology-Lung Cellular and Molecular Physiology
  • "The Role of Regulatory T Cells in Pulmonary Arterial Hypertension" (2021) published in Frontiers in Immunology
  • "Angiotensin converting enzyme 2 and angiotensin (1-7) axis in pulmonary arterial hypertension" (2020) published in European Respiratory Journal
  • "Impact of Proactive Integrated Care on Chronic Obstructive Pulmonary Disease" (2020) published in Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation

Frequent collaborators in Norbert F. Voelkel's research include:

  • Harm Jan Bogaard (3 joint publications)
  • Anna Birnhuber (2 joint publications)
  • Leigh M. Marsh (2 joint publications)
  • Grażyna Kwapiszewska (2 joint publications)
  • Wolfgang M. Kuebler (2 joint publications)

Norbert F. Voelkel has published multiple studies in several scientific venues, with recurring publications in:

  • American Journal of Physiology-Lung Cellular and Molecular Physiology
  • Journal of Clinical Investigation
  • American Journal of Respiratory Cell and Molecular Biology
  • Frontiers in Immunology
  • European Respiratory Journal

The scientist has been recognized as a member of the Association of American Physicians.

Best Publications

  • Cellular and molecular pathobiology of pulmonary arterial hypertension.

    Marc Humbert;Nicholas W. Morrell;Stephen L. Archer;Kurt R. Stenmark

  • Right Ventricular Function and Failure Report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure

    Norbert F. Voelkel;Robert A. Quaife;Leslie A. Leinwand;Robyn J. Barst

  • Inhibition of VEGF receptors causes lung cell apoptosis and emphysema

    Yasunori Kasahara;Rubin M. Tuder;Laimute Taraseviciene-Stewart;Timothy D. Le Cras

  • Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension

    Rubin M. Tuder;Carlyne D. Cool;Mark W. Geraci;Jun Wang

  • Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.

    R. M. Tuder;B. Groves;D. B. Badesch;N. F. Voelkel

  • Right Heart Adaptation to Pulmonary Arterial Hypertension: Physiology and Pathobiology

    Anton Vonk-Noordegraaf;François Haddad;Kelly M. Chin;Paul R. Forfia

  • Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

    Laimute Taraseviciene-Stewart;Yasunori Kasahara;Lori Alger;Peter Hirth

  • The Right Ventricle Under Pressure: Cellular and Molecular Mechanisms of Right-Heart Failure in Pulmonary Hypertension

    Harm J. Bogaard;Kohtaro Abe;Anton Vonk Noordegraaf;Norbert F. Voelkel

  • Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema.

    Yasunori Kasahara;Rubin M. Tuder;Carlyne D. Cool;David A. Lynch

  • Inflammation, growth factors, and pulmonary vascular remodeling.

    Paul M. Hassoun;Luc Mouthon;Joan A. Barberà;Saadia Eddahibi

  • Inhibition of angiogenesis decreases alveolarization in the developing rat lung.

    Malathi Jakkula;Timothy D. Le Cras;Sarah Gebb;K. Peter Hirth

  • Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.

    R M Tuder;B E Flook;N F Voelkel

  • Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.

    Brian D. Lowes;Wayne Minobe;William T. Abraham;Mona N. Rizeq

  • The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse

    Eleonora Mezzaroma;Stefano Toldo;Daniela Farkas;Ignacio M. Seropian

  • Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis

    Rubin M. Tuder;Mati Chacon;Lori Alger;Jun Wang

  • Chronic Pulmonary Artery Pressure Elevation Is Insufficient to Explain Right Heart Failure

    Harm J. Bogaard;Ramesh Natarajan;Scott C. Henderson;Carlin S. Long

  • Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model.

    C C Silliman;N F Voelkel;J D Allard;D J Elzi

  • Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.

    S D Lee;K R Shroyer;N E Markham;C D Cool

  • Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.

    S W Chang;C O Feddersen;P M Henson;N F Voelkel

  • Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure.

    Timothy D. Le Cras;Neil E. Markham;Rubin M. Tuder;Norbert F. Voelkel

Frequent Co-Authors

Rubin M. Tuder
Rubin M. Tuder University of Colorado Denver
Carlyne D. Cool
Carlyne D. Cool University of Colorado Denver
Antonio Abbate
Antonio Abbate University of Virginia
John T. Reeves
John T. Reeves University of Colorado Anschutz Medical Campus
David B. Badesch
David B. Badesch University of Colorado Denver
Robert C. Murphy
Robert C. Murphy University of Colorado Denver
Kurt R. Stenmark
Kurt R. Stenmark University of Colorado Anschutz Medical Campus
Marlene Rabinovitch
Marlene Rabinovitch Stanford University
Ivan F. McMurtry
Ivan F. McMurtry University of South Alabama
Charles A. Dinarello
Charles A. Dinarello University of Colorado Anschutz Medical Campus

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can broaden your opportunities beyond the traditional MD track. Many students are choosing to enroll in nursing schools with high acceptance rates, which can offer a more accessible entry point into the field. These programs often have flexible admission requirements while still providing valuable clinical experience.

For those interested in the administrative or technical sides of healthcare, medical billing and coding schools that accept financial aid can be an excellent choice. These online programs make it easier to gain industry credentials without the financial burden often associated with higher education.

Some students might prefer to avoid standardized testing. Luckily, there are nursing school no entrance exam options available, streamlining the admission process and allowing a faster start in your nursing career.

If you're interested in leadership roles within the healthcare sector, a healthcare administration degree online accredited can provide the skills needed for management positions. These accelerated programs are ideal for those seeking career advancement without putting their lives on hold.

Best Scientists Citing Norbert F. Voelkel

Trending Scientists

Recently Published Articles